Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum

Phase 2

Recruiting

Conditions: Desmoplastic Small Round Cell Tumor
Peritoneal Cancer
Peritoneal Carcinoma

Interventions: Drug: 131 I-omburtamab
Radiation: WAP-IMRT

First Posted Date: 2019-07-17

Last Posted Date: 2024-08-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 55

Registration Number: NCT04022213

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

Phase 1

Active, not recruiting

Conditions: Prostate Cancer
Castration-resistant Prostate Cancer
Prostate Neoplasm
Prostate Adenocarcinoma
Prostate Cancer Metastatic

Interventions: Drug: Talazoparib
Drug: Temozolomide

First Posted Date: 2019-07-15

Last Posted Date: 2024-10-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT04019327

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Virginia, Charlottesville, Virginia, United States

and more 6 locations

A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

Phase 2

Active, not recruiting

Conditions: CMV
CMV Infection
Hematopoietic Cell Transplant

Interventions: Drug: Letermovir Pill
Other: blood draw

First Posted Date: 2019-07-12

Last Posted Date: 2024-08-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 102

Registration Number: NCT04017962

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Psychotherapy Intervention for Latinos With Advanced Cancer

Not Applicable

Recruiting

Conditions: Solid Tumor, Unspecified, Adult
Solid Tumor, Adult
Solid Tumor

Interventions: Behavioral: Meaning Centered Psychotherapy for Latinos
Behavioral: Functional Assessment of Cancer Therapy - Spiritual Well-Being Scale
Behavioral: Meaning Centered Psychotherapy for Latinos for Waitlist Control Patients
Behavioral: Pre-assessment questionnaire

First Posted Date: 2019-07-11

Last Posted Date: 2024-06-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 190

Registration Number: NCT04015609

Locations: 🇺🇸
Lincoln Medical and Mental Health Center, Bronx, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Ralph Lauren Center for Cancer Care and Prevention, New York, New York, United States

and more 1 locations

Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction

Phase 4

Active, not recruiting

Conditions: Breast Cancer
Breast Cancer Female

Interventions: Drug: PVB Protocol
Drug: PECS-1
Drug: Serratus

First Posted Date: 2019-07-11

Last Posted Date: 2024-06-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1507

Registration Number: NCT04016376

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Acupuncture Pilot Study for Cancer-related Cognitive Function

Phase 2

Active, not recruiting

Conditions: Stage I Colorectal Cancer
Stage III Colorectal Cancer
Stage I Gynecologic Cancer
Stage I Breast Cancer
Stage III Breast Cancer
Stage II Gynecologic Cancer
Stage III Gynecologic Cancer
Stage I Prostate Cancer
Stage III Prostate Cancer
Stage II Prostate Cancer

Interventions: Other: Acupuncture
Other: Sham Acupuncture
Other: 16 week waiting period + optional Acupuncture

First Posted Date: 2019-07-05

Last Posted Date: 2024-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 48

Registration Number: NCT04007770

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States

and more 3 locations

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

Phase 2

Active, not recruiting

Conditions: Lung Cancer
NSCLC Stage II
Nsclc
Non Small Cell Lung Cancer
NSCLC, Stage III

Interventions: Radiation: Radiation Therapy
Drug: Durvalumab

First Posted Date: 2019-06-27

Last Posted Date: 2024-10-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 61

Registration Number: NCT03999710

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 6 locations

Researching the Effect of Aerobic Exercise on Cancer

Not Applicable

Recruiting

Conditions: Cancer

Interventions: Behavioral: exercise (walking)
Other: plasma samples
Other: blood draw

First Posted Date: 2019-06-24

Last Posted Date: 2024-12-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 52

Registration Number: NCT03996239

Locations: 🇺🇸
University of California, Los Angeles (Data or Specimen Analysis Only), Los Angeles, California, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States

and more 7 locations

Supportive Care Needs of Caregivers of People With Erdheim-Chester Disease and Other Histiocytic Diseases

Recruiting

Conditions: Supportive Care Needs of Caregivers

Interventions: Behavioral: online surveys

First Posted Date: 2019-06-19

Last Posted Date: 2024-06-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 170

Registration Number: NCT03990428

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-associated Malignancies

Phase 2

Withdrawn

Conditions: EBV Lymphomas
EBV-associated Malignancies

Interventions: Biological: EBV-specific T-cells

First Posted Date: 2019-06-17

Last Posted Date: 2020-06-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT03988582

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy